Neurology® Podcast

  • Autor: Vários
  • Narrador: Vários
  • Editor: Podcast
  • Duración: 618:02:00
  • Mas informaciones

Informações:

Sinopsis

The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation. Opening segments include interviews with authors who summarize a current article and discuss the main findings and clinical implications for neurologists. Regular features also include the Lesson of the Week, Delayed Recall, Whats Trending, and selected content from Neurology® Today. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits by answering the multiple-choice questions related to Neurology content in the online Podcast Quiz. (Delayed Recall, Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation contents are excluded from the CME program). The exams are posted weekly on Tuesday.

Episodios

  • From the Mailbox to the Microphone - Part 1

    From the Mailbox to the Microphone - Part 1

    16/11/2026 Duración: 18min

    In part one of this series, Dr. Stacey Clardy talks with Drs. Jeff Ratliff, Andy Southerland, and Jason Crowell about the evolution of the Neurology® Podcast, from Ted Burns's founding vision to the conversations and formats that have connected with listeners for nearly two decades. Read the related article in Neurology®.  Nominations for the 2027 Ted M. Burns Humanism in Neurology Award will be open until December 18, 2026, at 3:00 pm CT.  Disclosures can be found at Neurology.org. 

  • Establishing Potosi Virus as a Human Pathogen - Part 2

    Establishing Potosi Virus as a Human Pathogen - Part 2

    12/11/2026 Duración: 13min

    In the second episode of this two-part series, Dr. Stacey Clardy talks with Dr. Justin Abbatemarco about the risks of immunosuppression for autoimmune neurologic diseases and how to optimize the benefits of immunotherapies while minimizing the associated risks.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org. 

  • Establishing Potosi Virus as a Human Pathogen - Part 1

    Establishing Potosi Virus as a Human Pathogen - Part 1

    09/11/2026 Duración: 19min

    In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Justin Abbatemarco about why infection can be overlooked in people on anti-CD20 therapy and practical ways clinicians can improve testing, prevention, vaccination, and collaboration with laboratories and infectious disease specialists.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org. 

  • Physicians as Patients: A Live On-stage Discussion

    Physicians as Patients: A Live On-stage Discussion

    05/11/2026 Duración: 25min

    In this special conversation, recorded live at this year's AAN Annual Meeting, Dr. Alison Christy talks with Drs. Franziska Herpich and Yolanda Holler-Managan about how personal experiences with stroke, disability, and caregiving have changed the way they understand and care for patients and families. Listen to the previous episode featuring Dr. Franziska Herpich.  Disclosures can be found at Neurology.org.

  • Youth Football and the Epidemic of Pediatric Brain Injury

    Youth Football and the Epidemic of Pediatric Brain Injury

    03/11/2026 Duración: 15min

    Dr. Dara Albert talks with Isaac Thorman about football-related traumatic brain injury in children and young adults and its association with later neurologic and psychiatric outcomes.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

  • November 2026 Recall: Updates in Neurodegenerative Disease: Diagnosis, Treatment, and Prevention

    November 2026 Recall: Updates in Neurodegenerative Disease: Diagnosis, Treatment, and Prevention

    01/11/2026 Duración: 01h10min

    The November 2026 Recall features four previously published episodes on updates in neurodegenerative disease diagnosis, treatment, and prevention. The episode begins with a two-part discussion with Drs. Trey Bateman and Gregg Day discussing highlights from the 2026 Alzheimer's Association International Conference. The episode continues with Drs. Sonia Vallabh and Eric Minikel discussing the future of prion disease treatment. The episode concludes with Dr. Pascal Geldsetzer discussing how the herpes zoster vaccination may have neuroprotective effects, potentially delaying or preventing dementia.  Podcast links: 2026 Alzheimer's Association International Conference Reports - Part 1 2026 Alzheimer's Association International Conference Reports - Part 2 Prion Disease Clinical Trial NN112 Herpes Zoster Vaccination and Incident Dementia in Canada Article links:  PrP-targeting siRNA Safety & Mechanism Study Herpes Zoster Vaccination and Incident Dementia in Canada Disclosures can be found at Neurology.org. 

  • Trends in Emergent Interfacility Ischemic Stroke Transfers

    Trends in Emergent Interfacility Ischemic Stroke Transfers

    29/10/2026 Duración: 15min

    Dr. Andy Southerland talks with Dr. Matthew Gusler about trends in emergent interfacility transfers for ischemic stroke and factors associated with transfer for care.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org. 

  • Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS

    Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS

    26/10/2026 Duración: 25min

    Dr. Zohaib Siddiqi talks with Dr. Michel Toledano about the diagnosis and management of infectious rhombencephalitis in patients receiving immunomodulatory therapy. Read the related Resident & Fellow Section article in Neurology®. Disclosures can be found at Neurology.org. 

  • Incidence and Prevalence of Conversions to MCI and Dementia in Patients With Essential Tremor

    Incidence and Prevalence of Conversions to MCI and Dementia in Patients With Essential Tremor

    22/10/2026 Duración: 13min

    Dr. Matthew Barrett talks with Dr. Elan Louis about the incidence and prevalence of mild cognitive impairment and dementia in essential tremor and what these findings may mean for patient care and future research.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org. 

  • The Menopause Transition and Epilepsy

    The Menopause Transition and Epilepsy

    19/10/2026 Duración: 20min

    Dr. Katie Krulisky talks with Dr. Kelsey Smith about the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife. Read the related article in Neurology®Clinical Practice.  Disclosures can be found at Neurology.org.  Podcast Transcript:  Dr. Jose Merino: This is Jose Merino, Editor-in-Chief of the Neurology Family of Journals. The Neurology Podcast provides practical information to neurologists and other clinicians to help them provide better care for their patients. Thanks for listening and have a great week. Dr. Katie Krulisky: Hello, and welcome to this episode of the Neurology Podcast. This is Katie Kruliski from the VA and University of Utah in Salt Lake City, Utah. Today, I have the pleasure of talking with Kelsey Smith. She's a neurologist and epileptologist at Mayo Clinic in Rochester, Minnesota. We will be discussing her recent paper published in the Neurology Clinical Practice Journal titled The Menopause Transition and Epilepsy: A Focus on Therapeut

  • Herpes Zoster Vaccination and Incident Dementia in Canada

    Herpes Zoster Vaccination and Incident Dementia in Canada

    15/10/2026 Duración: 15min

    Dr. Margarita Fedorova talks with Dr. Pascal Geldsetzer about how the herpes zoster vaccination may have neuroprotective effects, potentially delaying or preventing dementia.  Read the related article in The Lancet Neurology. Disclosures can be found at Neurology.org.  Podcast Transcript:  Dr. José Merino: This is José Merino, editor-in-chief of the Neurology Family of Journals. The Neurology Podcast provides practical information to neurologists and other clinicians to help them provide better care for their patients. Thanks for listening and have a great week. Dr. Margarita Fedorova: Hi, this is Margarita Fedorova and I'm a neurology resident at the Cleveland Clinic. Today, we're exploring a study that speaks to an idea that's been building for a few years now, that vaccination itself might be neuroprotective. I'm here with Pascal Geldsetzer, a physician and epidemiologist at Stanford University. Pascal is the author on a paper published in the February 2026 issue of Lancet Neurology titled "Herpes Zoster

  • Understanding the Forces Shaping US Health Care

    Understanding the Forces Shaping US Health Care

    12/10/2026 Duración: 21min

    Dr. Jason Crowell talks with Dr. John McDonough about the historical and economic factors shaping the US healthcare system and why understanding these systemic forces matters for neurologists and patient care.  Read the related article in The Harvard Gazette.  Disclosures can be found at Neurology.org.   

  • Prevalence of CTE at Death in National Football League Players

    Prevalence of CTE at Death in National Football League Players

    08/10/2026 Duración: 25min

    Dr. Shuvro Roy talks with Dr. Daniel Daneshvar about the prevalence of CTE at death among NFL players and the association between CTE severity and the risk of dementia.  Read the related article in the BMJ.  Disclosures can be found at Neurology.org. 

  • Clinical Manifestations of Primary CNS T Cell Lymphoma

    Clinical Manifestations of Primary CNS T Cell Lymphoma

    05/10/2026 Duración: 14min

    Dr. Kait Nevel talks with Dr. Katharina Schmidbauer about primary CNS T-cell lymphoma, highlighting diagnostic challenges, imaging characteristics, and treatment approaches for this rare disease.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org. 

  • October 2026 Recall: Updates in Immune-Based Therapies for Neurologic Disease

    October 2026 Recall: Updates in Immune-Based Therapies for Neurologic Disease

    02/10/2026 Duración: 01h04min

    The October Recall features four previously posted episodes on immune‑based therapies for neurologic disease. In the first episode, Dr. Bhaskar Roy reviews the latest treatments, comparing their efficacy and safety. The second episode, with Dr. Michael Levy, focuses on satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy. That conversation leads into an episode with Dr. Amanda L. Piquet, who discusses the efficacy and safety of miv-cel in patients with stiff person syndrome. The episode concludes with Dr. Irene Cortese highlighting recent advances in the treatment of PML.  Podcast links:  Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome Resolution of PML after Treatment with Virus-Specific T Cells and HCT Article links: Comparison of the Efficacy and Safety of Myasthenia

  • The Future of Child Neurology Residency Training

    The Future of Child Neurology Residency Training

    01/10/2026 Duración: 21min

    Dr. Dara Albert talks with Dr. Bruce Cohen about the future of child neurology residency training, exploring current models, consensus areas, and challenges in evolving the curriculum to meet future healthcare needs. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org. 

  • Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations

    Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations

    28/09/2026 Duración: 22min

    Dr. Tesha Monteith talks with Dr. Tamara Pringsheim about the updated American Academy of Neurology (AAN) and American Headache Society (AHS) guidelines on pharmacologic treatment for migraine prevention in adults.  Read the related article in Neurology®. Disclosures can be found at Neurology.org.  Show transcript:  Dr. Jose Merino (00:08): This is Jose Merino, editor-in-chief of the Neurology Family of Journals. The Neurology Podcast provides practical information to neurologists and other clinicians to help them provide better care for their patients. Thanks for listening and have a great week. Dr. Tesha Monteith (00:23): Hi, this is Tesha Monteith with the Neurology Podcast. I'm excited to talk to you today about the update in Migraine Guideline: Pharmacologic Treatment for Migraine Prevention in Adults: Practice Guideline Recommendations, a report of the American Academy Neurology Guidelines Subcommittee, and the American Headache Society. Since the last guideline in 2012, there's been a lot of new advanc

  • Resolution of PML after Treatment with Virus-Specific T Cells and HCT

    Resolution of PML after Treatment with Virus-Specific T Cells and HCT

    24/09/2026 Duración: 21min

    Dr. Justin Abbatemarco talks with Dr. Irene Cortese about recent advances in the treatment of progressive multifocal leukoencephalopathy (PML), focusing on immune-based therapies like virus-specific T cells and immune checkpoint inhibitors.  Read the related article in The New England Journal of Medicine.  Disclosures can be found at Neurology.org.  Show transcript:  Dr. José Merino: This is José Merino, editor-in-chief of the Neurology Family of Journals. The Neurology Podcast provides practical information to neurologists and other clinicians to help them provide better care for their patients. Thanks for listening, and have a great week. Dr. Justin Abbatemarco: Hello and welcome. This is Justin Abbatemarco with the Cleveland Clinic here with Irene Cortese to discuss an update on progressive multifocal leukoencephalopathy treatment in light of a New England Journal of Medicine correspondence, Resolution of PML After Treatment with Virus-Specific T Cells and HCT. Irene directs the Experimental Immunotherapeu

  • Primary Motor Cortex Involvement and Seizure Risk in Patients With Brain Metastases

    Primary Motor Cortex Involvement and Seizure Risk in Patients With Brain Metastases

    21/09/2026 Duración: 13min

    Dr. Kait Nevel talks with Drs. Ayal Aizer and Clara Baselga-Garriga about the link between primary motor cortex involvement in brain metastases and increased seizure risk, highlighting implications for patient management and future research directions.  Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

  • Marijuana Rescheduling: What It Means for Neurology Research and Care

    Marijuana Rescheduling: What It Means for Neurology Research and Care

    17/09/2026 Duración: 27min

    Dr. John Ney talks with Dr. Daniele Piomelli about the evolving role of cannabis in neurology, exploring its history, current research, and potential future applications. Read the related article in The New England Journal of Medicine.  Disclosures can be found at Neurology.org. 

página 1 de 71